Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Ciproxifan maleate
Cat. No.:
OB0225LY-0131
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Ciproxifan maleate is an antihistamine and sedative drug that is an H3 histamine receptor antagonist.
Synonym:
FUB 359 maleate; FUB 359; 184025-19-2; Ciproxifan (maleate); (4-(3-(1H-Imidazol-5-yl)propoxy)phenyl)(cyclopropyl)methanone maleate; (Z)-But-2-enedioic acid cyclopropyl-[4-[3-(1H-imidazol-5-yl)propoxy]phenyl]methanone; (4-(3-(1H-Imidazol-4-yl)propoxy)phenyl)(cyclopropyl)methanone maleate; Cyclopropyl (4-[3-(1H-imidazol-4-yl)propyloxy]phenyl) ketone maleate salt
CAS No.:
184025-19-2
Compound CID:
16219152
Formula:
C20H22N2O6
Formula Weight:
386.4
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Ciproxifan maleate can be used to enhance cognitive function, improve concentration and treat narcolepsy.
Library Information
Targets:
Histamine receptor
Receptors:
H3 receptor
Pathways:
GPCR/G protein; Immunology/Inflammation; Neuronal signaling
Plate Number:
AOCL-2
Plate Location:
f4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 129.4 mM
Ethanol Max Solubility:
54 mg/mL; 139.75 mM
